Circulation. 2003;108:833-838
Published online before print August 11, 2003, doi: 10.1161/01.CIR.0000084543.79097.34
Published online before print August 11, 2003, doi: 10.1161/01.CIR.0000084543.79097.34
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:833.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure
From Ahmanson-UCLA Cardiomyopathy Center, University of California–Los Angeles Division of Cardiology, Los Angeles, Calif.
Correspondence to Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1679. E-mail gfonarow{at}mednet.ucla.edu
Received November 19, 2002; de novo received March 13, 2003; revision received May 12, 2003; accepted May 12, 2003.
Background— Cardiac troponin I (cTnI), a sensitive and specific marker of myocardial cell injury, is useful in diagnosing and assessing prognosis in acute coronary syndromes. Small studies report that cTnI is elevated in severe heart failure (HF) and may predict adverse outcomes.
Methods and Results— The present study evaluated 238 patients with advanced HF referred for cardiac transplantation evaluation who had cTnI assay drawn at the time of initial presentation. Patients with acute myocardial infarction or myocarditis were excluded from analysis. cTnI was detectable (cTnI 
0.04 ng/mL) in serum of 117 patients (49.1%). Patients with detectable cTnI levels had significantly higher B-type natriuretic peptide (BNP) levels (P<0.001) and more impaired hemodynamic profiles, including higher pulmonary wedge pressures (P=0.002) and lower cardiac indexes (P<0.0001). A significant correlation was found between detectable cTnI and progressive decline in ejection fraction over time. Furthermore, detectable cTnI was associated with increased mortality risk (RR, 2.05; 95% CI, 1.22 to 3.43). After adjustment for other factors associated with adverse prognosis including age, sex, ejection fraction, and coronary artery disease, cTnI remained a significant predictor of death. cTnI used in conjunction with BNP further improved prognostic value.
Conclusions— cTnI is associated with impaired hemodynamics, elevated BNP levels, and progressive left ventricular dysfunction in patients with HF. cTnI may be a novel, useful tool in identifying patients with HF who are at increased risk for progressive ventricular dysfunction and death.
Key Words: hemodynamics • natriuretic peptides • mortality • heart failure • tests
This article has been cited by other articles:
 |
|
 |
|
  W. L. Miller, K. A. Hartman, M. F. Burritt, D. E. Grill, and A. S. Jaffe Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1715 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Venkateswaran, J. S. Ganesh, J. Thekkudan, R. Steeds, I. C. Wilson, J. Mascaro, R. Thompson, and R. S. Bonser Donor cardiac troponin-I: a biochemical surrogate of heart function Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 286 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Shah, A. A. Chen-Tournoux, M. H. Picard, and J. L. Januzzi Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function Eur J Echocardiogr, August 1, 2009; 10(6): 765 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Blendea, M Blendea, J Banker, and C A McPherson Troponin T elevation after implanted defibrillator discharge predicts survival Heart, July 15, 2009; 95(14): 1153 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sbarouni, P. Georgiadou, M. Koutelou, I. Sklavainas, D. Panagiotakos, and V. Voudris Ischaemia-modified albumin in dilated cardiomyopathy Ann Clin Biochem, May 1, 2009; 46(3): 241 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sundstrom, E. Ingelsson, L. Berglund, B. Zethelius, L. Lind, P. Venge, and J. Arnlov Cardiac troponin-I and risk of heart failure: a community-based cohort study Eur. Heart J., April 1, 2009; 30(7): 773 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade and P. S. Pang Acute heart failure syndromes. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 557 - 573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Flaherty, J. J. Bax, L. De Luca, J. S. Rossi, C. J. Davidson, G. Filippatos, P. P. Liu, M. A. Konstam, B. Greenberg, M. R. Mehra, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 254 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Kaya, S. Goser, S. J. Buss, F. Leuschner, R. Ottl, J. Li, M. Volkers, S. Zittrich, G. Pfitzer, N. R. Rose, et al. Identification of Cardiac Troponin I Sequence Motifs Leading to Heart Failure by Induction of Myocardial Inflammation and Fibrosis Circulation, November 11, 2008; 118(20): 2063 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Eggers, L. Lind, H. Ahlstrom, T. Bjerner, C. Ebeling Barbier, A. Larsson, P. Venge, and B. Lindahl Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects Eur. Heart J., September 2, 2008; 29(18): 2252 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tunca, M. Sozmen, H. Erdogan, M. Citil, E. Uzlu, H. Ozen, and E. Gokce Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease J Vet Diagn Invest, September 1, 2008; 20(5): 598 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ilva, J. Lassus, K. Siirila-Waris, J. Melin, K. Peuhkurinen, K. Pulkki, M. S. Nieminen, H. Mustonen, P. Porela, and V.-P. Harjola Clinical significance of cardiac troponins I and T in acute heart failure Eur J Heart Fail, August 1, 2008; 10(8): 772 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Peacock IV, T. De Marco, G. C. Fonarow, D. Diercks, J. Wynne, F. S. Apple, A. H.B. Wu, and the ADHERE Investigators Cardiac Troponin and Outcome in Acute Heart Failure N. Engl. J. Med., May 15, 2008; 358(20): 2117 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Braunwald Biomarkers in Heart Failure N. Engl. J. Med., May 15, 2008; 358(20): 2148 - 2159. [Full Text] [PDF]
|
|
|
|
|
|
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition Eur. Heart J., February 1, 2008; 29(3): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality Circulation, October 23, 2007; 116(17): 1907 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang Significance of Circulating Troponins in Heart Failure: If These Walls Could Talk Circulation, September 11, 2007; 116(11): 1217 - 1220. [Full Text] [PDF]
|
|
|
|
|
|
R. Latini, S. Masson, I. S. Anand, E. Missov, M. Carlson, T. Vago, L. Angelici, S. Barlera, G. Parrinello, A. P. Maggioni, et al. Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure Circulation, September 11, 2007; 116(11): 1242 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, S. Nodari, G. Parrinello, C. Specchia, L. Brentana, P. Rocca, F. Fracassi, T. Bordonali, P. Milani, R. Danesi, et al. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T Eur J Heart Fail, August 1, 2007; 9(8): 776 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.H. Wilson Tang, G. S. Francis, D. A. Morrow, L. K. Newby, C. P. Cannon, R. L. Jesse, A. B. Storrow, R. H. Christenson, COMMITTEE MEMBERS, R. H. Christenson, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure Circulation, July 31, 2007; 116(5): e99 - e109. [Full Text] [PDF]
|
|
|
|
|
|
W. L. Miller, K. A. Hartman, M. F. Burritt, D. E. Grill, R. J. Rodeheffer, J. C. Burnett Jr, and A. S. Jaffe Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time Circulation, July 17, 2007; 116(3): 249 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dorenkamp, M. Zabel, and C. Sticherling Role of Coronary Angiography Before Radiofrequency Ablation in Patients Presenting With Paroxysmal Supraventricular Tachycardia Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 137 - 144. [Abstract] [PDF]
|
|
|
|
|
|
J. G.F. Cleland, R. Shelton, N. Nikitin, S. Ford, L. Frison, and M. Grind Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials Eur J Heart Fail, June 1, 2007; 9(6-7): 730 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sakhuja, S. Green, E. M. Oestreicher, P. M. Sluss, E. Lee-Lewandrowski, K. B. Lewandrowski, and J. L. Januzzi Jr. Amino-Terminal Pro-Brain Natriuretic Peptide, Brain Natriuretic Peptide, and Troponin T for Prediction of Mortality in Acute Heart Failure Clin. Chem., March 1, 2007; 53(3): 412 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Madsen, G. Christensen, T. Lund, V. L. Serebruany, C. B. Granger, I. Hoen, Z. Grieg, J. H. Alexander, A. S. Jaffe, J. E. Van Eyk, et al. Time Course of Degradation of Cardiac Troponin I in Patients With Acute ST-Elevation Myocardial Infarction: The ASSENT-2 Troponin Substudy Circ. Res., November 10, 2006; 99(10): 1141 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goser, M. Andrassy, S. J. Buss, F. Leuschner, C. H. Volz, R. Ottl;, S. Zittrich;, N. Blaudeck, S. E. Hardt, G. Pfitzer, et al. Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium Circulation, October 17, 2006; 114(16): 1693 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. O. Adesanya, J. A. de Lemos, N. B. Greilich, and C. W. Whitten Management of perioperative myocardial infarction in noncardiac surgical patients. Chest, August 1, 2006; 130(2): 584 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maeder, T. Fehr, H. Rickli, and P. Ammann Sepsis-Associated Myocardial Dysfunction: Diagnostic and Prognostic Impact of Cardiac Troponins and Natriuretic Peptides Chest, May 1, 2006; 129(5): 1349 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Wallace, S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos Prevalence and Determinants of Troponin T Elevation in the General Population Circulation, April 25, 2006; 113(16): 1958 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Stevenson, T. H. Le Jemtel, E. U. Alt, L. W. Stevenson, T. H. Le Jemtel, and E. U. Alt Hemodynamic Goals Are Relevant Circulation, February 21, 2006; 113(7): 1020 - 1033. [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. L. Pina, M. A. Konstam, B. M. Massie, E. Roland, S. Targum, S. P. Collins, et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research Circulation, December 20, 2005; 112(25): 3958 - 3968. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Minkin, D. Cotiga, S. Noack, A. Dobrescu, P. Homel, and J. M. Shapiro Use of Admission Troponin in Critically Ill Medical Patients J Intensive Care Med, December 1, 2005; 20(6): 286 - 290. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Babuin and A. S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jeremias and C. M. Gibson Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded Ann Intern Med, May 3, 2005; 142(9): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Thielmann, P. Massoudy, M. Neuhauser, S. Knipp, M. Kamler, G. Marggraf, J. Piotrowski, and H. Jakob Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 861 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gheorghiade and F. Zannad Modern management of acute heart failure syndromes Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B3 - B7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Perna, S. M. Macin, J. P. C. Canella, N. Augier, J. L. R. Stival, J. R. Cialzeta, A. E. Pitzus, E. H. Garcia, R. Obregon, M. Brizuela, et al. Ongoing Myocardial Injury in Stable Severe Heart Failure: Value of Cardiac Troponin T Monitoring for High-Risk Patient Identification Circulation, October 19, 2004; 110(16): 2376 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Sato, T Kita, Y Takatsu, and T Kimura Biochemical markers of myocyte injury in heart failure Heart, October 1, 2004; 90(10): 1110 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Landesberg, M. Mosseri, V. Shatz, I. Akopnik, M. Bocher, M. Mayer, H. Anner, Y. Berlatzky, and C. Weissman Cardiac troponin after major vascular surgery: The role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization J. Am. Coll. Cardiol., August 4, 2004; 44(3): 569 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Panteghini Role and importance of biochemical markers in clinical cardiology Eur. Heart J., July 2, 2004; 25(14): 1187 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kemp, J. Donovan, H. Higham, and J. Hooper Biochemical markers of myocardial injury Br. J. Anaesth., July 1, 2004; 93(1): 63 - 73. [Abstract] [Full Text] [PDF]
|
|